191 related articles for article (PubMed ID: 17109444)
1. A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.
Smirnoff P; Roiz L; Angelkovitch B; Schwartz B; Shoseyov O
Cancer; 2006 Dec; 107(12):2760-9. PubMed ID: 17109444
[TBL] [Abstract][Full Text] [Related]
2. ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics.
Roiz L; Smirnoff P; Bar-Eli M; Schwartz B; Shoseyov O
Cancer; 2006 May; 106(10):2295-308. PubMed ID: 16586499
[TBL] [Abstract][Full Text] [Related]
3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay A; López-Casillas F; Malik SN; Montiel JL; Mendoza V; Yang J; Sun LZ
Cancer Res; 2002 Aug; 62(16):4690-5. PubMed ID: 12183427
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2.
Campomenosi P; Cinquetti R; Tallarita E; Lindqvist C; Raimondi I; Grassi P; Näsman J; Dell A; Haslam SM; Taramelli R; Acquati F
Biotechnol Appl Biochem; 2011; 58(1):39-49. PubMed ID: 21446958
[TBL] [Abstract][Full Text] [Related]
6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenesis and anti-tumor activity of recombinant anginex.
Brandwijk RJ; Dings RP; van der Linden E; Mayo KH; Thijssen VL; Griffioen AW
Biochem Biophys Res Commun; 2006 Oct; 349(3):1073-8. PubMed ID: 16970922
[TBL] [Abstract][Full Text] [Related]
8. [Endothelial genesis inhibitor-8t (EDI-8t) against tumor growth].
Zhou Q; Du P; Qian Y; Zhang Q; Feng B; Ding H; Gan R; Zhang H
Sheng Wu Gong Cheng Xue Bao; 2010 Dec; 26(12):1724-31. PubMed ID: 21387837
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent.
Nesiel-Nuttman L; Schwartz B; Shoseyov O
Oncotarget; 2014 Nov; 5(22):11464-78. PubMed ID: 25426551
[TBL] [Abstract][Full Text] [Related]
10. High-level expression, purification, and characterization of recombinant human basic fibroblast growth factor in Pichia pastoris.
Mu X; Kong N; Chen W; Zhang T; Shen M; Yan W
Protein Expr Purif; 2008 Jun; 59(2):282-8. PubMed ID: 18378165
[TBL] [Abstract][Full Text] [Related]
11. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
12. Tumor and metastasis suppression by the human RNASET2 gene.
Acquati F; Possati L; Ferrante L; Campomenosi P; Talevi S; Bardelli S; Margiotta C; Russo A; Bortoletto E; Rocchetti R; Calza R; Cinquetti R; Monti L; Salis S; Barbanti-Brodano G; Taramelli R
Int J Oncol; 2005 May; 26(5):1159-68. PubMed ID: 15809705
[TBL] [Abstract][Full Text] [Related]
13. The 1.8 Å crystal structure of ACTIBIND suggests a mode of action for T2 ribonucleases as antitumorigenic agents.
de Leeuw M; González A; Lanir A; Roiz L; Smirnoff P; Schwartz B; Shoseyov O; Almog O
J Med Chem; 2012 Feb; 55(3):1013-20. PubMed ID: 22216760
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification and biological characterization of human vasostatin120-180 in Pichia pastoris.
Lin Y; Yang X; Lu M; Zhuang H; Hua ZC
Protein Expr Purif; 2013 Dec; 92(2):141-7. PubMed ID: 24096091
[TBL] [Abstract][Full Text] [Related]
17. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
20. [Expression and characterization of Kringle 1-5 domains of human plasminogen].
Zhou QW; Xie JL; Xin L; Ye Q; Li ZP; Gan RB
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Aug; 35(8):761-7. PubMed ID: 12897974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
